Pancreatic cancer: resistance factor to new molecular therapies identified
(Adnkronos) - Mutations in the KRAS gene are a defining characteristic of pancreatic ductal adenocarcinoma, the most common and aggressive form of pancreatic cancer, and drive its onset and progression. In recent years, the development of drugs targeting the KRAS protein...